Subgroup Analysis by Prior Treatment of the Efficacy and Safety of Panobinostat Plus Bortezomib and Dexamethasone in Patients With Relapsed or Relapsed and Refractory Multiple Myeloma in the PANORAMA 1 Study

Saved in:
Bibliographic Details
Published in:Clinical lymphoma, myeloma and leukemia myeloma and leukemia, 2015-09, Vol.15, p.e78-e78
Main Authors: Richardson, P.G, Hungria, V.T.M, Yoon, S.-S, Beksac, M, Dimopoulos, M.A, Elghandour, A, Jedrzejczak, W.W, Guenther, A, Nakorn, T.N, Siritanaratkul, N, Schlossman, R.L, Hou, J, Moreau, P, Lonial, S, Lee, J.H, Einsele, H, Sopala, M, Bengoudifa, B.R, Corrado, C, San-Miguel, J.F
Format: Article
Language:English
Subjects:
Hematology, Oncology and Palliative Medicine
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:2152-2650
2152-2669
DOI:10.1016/j.clml.2015.07.231